Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency

about

Immunodeficiency due to mutations in ORAI1 and STIM1.Evaluation of the child with suspected primary immunodeficiency.Defective interleukin-2 R gene expression in gastric carcinoma patients.

P2860

Q37699956-60E94E50-97CD-454F-A9EF-D996E6B5012E Q40426774-3A309035-A07F-409E-BC7C-34C963858581 Q53464214-C9EE9F51-0B12-4EB6-B75E-E3B9BE3EAA3F

P2860

Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency

Item

http://www.wikidata.org/entity/Q36316830

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Molecular basis of a multiple ...... vere combined immunodeficiency

@ast

Molecular basis of a multiple ...... vere combined immunodeficiency

@en

type

Item

label

Molecular basis of a multiple ...... vere combined immunodeficiency

@ast

Molecular basis of a multiple ...... vere combined immunodeficiency

@en

prefLabel

Molecular basis of a multiple ...... vere combined immunodeficiency

@ast

Molecular basis of a multiple ...... vere combined immunodeficiency

@en

P1476

Molecular basis of a multiple ...... vere combined immunodeficiency

@en

P2093

E Castigli

http://www.w3.org/2001/XMLSchema#string

R A Good

http://www.w3.org/2001/XMLSchema#string

R Pahwa

http://www.w3.org/2001/XMLSchema#string

R S Geha

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

Identification of a zinc finger protein that inhibits IL-2 gene expression

Characterization of antigen receptor response elements within the interleukin-2 enhancer

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Recombinant interleukin 2 therapy in severe combined immunodeficiency disease

A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor

The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter

The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2.

Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.

P304

4728-4732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.90.10.4728

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Talal A Chatila

P577

1993-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14693645

http://www.w3.org/2001/XMLSchema#string

P698

8506326

http://www.w3.org/2001/XMLSchema#string

P932

46586

http://www.w3.org/2001/XMLSchema#string

Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency

about

P2860

P2860

Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932